Skip to content
Colorectal Cancer Clinical Trials

Oklahoma City, Oklahoma

Colorectal cancer clinical trials in Oklahoma City, OK

28 colorectal cancer studies are recruiting participants at sites in Oklahoma City as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Oklahoma City at a glance

  • 28 studies are recruiting at a site in Oklahoma City.
  • By phase: Phase 1 (8), Phase 1/2 (7), Phase 2 (1), Phase 2/3 (1), Phase 3 (2), No phase (5), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (15), university, hospital or other (8), government (5).
  • Most recent update to one of these records: November 13, 2026.

Studies recruiting in Oklahoma City

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Mercy Coletta Cancer Center
    Registry record
    NCT07488676 · updated
  2. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT06102902 · updated
  3. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT06995898 · updated
  4. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Mercy Hospital Oklahoma City
    Registry record
    NCT07018869 · updated
  5. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  6. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Mercy Hospital Oklahoma City · Veterans Administration Medical Center - Oklahoma City
    Registry record
    NCT05080673 · updated
  7. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Integris Cancer Institute of Oklahoma · Integris Southwest Medical Center · Mercy Hospital Oklahoma City
    Registry record
    NCT05174169 · updated
  8. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mercy Hospital Oklahoma City
    Registry record
    NCT05334069 · updated
  9. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Mercy Hospital Oklahoma City
    Registry record
    NCT06418204 · updated
  10. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mercy Hospital Oklahoma City
    Registry record
    NCT07283939 · updated
  11. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    OU Health Stephenson Cancer Center
    Registry record
    NCT06720987 · updated
  12. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mercy Hospital Oklahoma City
    Registry record
    NCT07143487 · updated
  13. Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT05803382 · updated
  14. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Stephenson Cancer Center
    Registry record
    NCT04657068 · updated
  15. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    OU Stephenson Cancer Center
    Registry record
    NCT06026410 · updated
  16. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    University of Oklahoma
    Registry record
    NCT04585750 · updated
  17. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    University of Oklahoma
    Registry record
    NCT06128551 · updated
  18. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Stephenson Cancer Center
    Registry record
    NCT06445062 · updated
  19. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    OU Health Stephenson Cancer Center
    Registry record
    NCT06253871 · updated
  20. Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT06696768 · updated
  21. A Study of DM002 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT06751329 · updated
  22. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  23. Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Oklahoma Health Sciences Center
    Registry record
    NCT05691491 · updated
  24. Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    University of Oklahoma
    Study site
    TSET Health Promotion Research Center
    Registry record
    NCT07254910 · updated
  25. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Study site
    Hightower Clinical
    Registry record
    NCT06937177 · updated
  26. Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Elephas
    Study site
    Mercy Hospital - OKC
    Registry record
    NCT07327489 · updated
  27. A Study of NX-1607 in Adults With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    University of Oklahoma
    Registry record
    NCT05107674 · updated
  28. Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Tempus AI
    Study site
    Mercy Clinic Oncology and Hematology - Coletta
    Registry record
    NCT05234177 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Oklahoma City, OK on ClinicalTrials.gov.

Ask about studies near Oklahoma City

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call